Could a Blood Test Detect Early-Stage Cancers? M Tontonoz, ASCO, June 2017

https://phgkb.cdc.gov/GAPPKB/phgHome.do


Last Posted: Jun 03, 2017

---

• Could a Blood Test Detect Early-Stage Cancers?  
  M Tontonoz, ASCO, June 2017
• The Truth Is in the Blood: The Evolution of Liquid Biopsies in Breast Cancer Management  
  MR Cruz et al, ASCO 2017 annual meeting
• Medical research: Personalized test tracks cancer relapse  
  A Bardelli, Nature News, May 2017
• NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?  
  Falk Alexander T et al. Expert review of anticancer therapy 2017 May 1-5
• Implementing liquid biopsies into clinical decision making for cancer immunotherapy.  
  Quandt Dagmar et al. Oncotarget 2017 Apr
• Liquid Biopsies Remain Wait and See for Some Clinicians  
  Gen BIO, May 15, 2017
• Circulating Tumor DNA as Biomarkers for Cancer Detection  
  X Han et al, Genomics, Proteomics and Bioinformatics, April 2017
• Liquid-biopsies success highlights power of combining basic and clinical research  
  Nature editorial, April 26, 2017
• Can A Simple Blood Test Really Spot Cancer Early? Don’t Bet On It Yet, Scientists Say.  
  SM Lee, Buzzfeed, April 13, 2017
• New blood test could help detect and locate cancer early on  
  Science Magazine, March 6, 2017
• New ‘blood biopsies’ with experimental device may improve cancer diagnosis and follow-up  
  Science Magazine, February 13, 2017
• Grail to pour $1 billion into blood test to detect early cancer  
  C Sheridan, Nat Biotechnology, February 7, 2017
• Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer  
  J Cavallo, ASCO Post, December 20, 2016
• Circulating tumor DNA technology: the future of cancer management?  
  L Blackburn, PHG Foundation, December 20, 2016
• Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study  
  CA Parkinson et al, PLOS Medicine, December 20, 2016
• KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients.  
  Garzón Mónica et al. Translational lung cancer research 2016 Oct 5(5) 511-516

more